Cargando…

Galectin‐3 and venous thromboembolism incidence: the Atherosclerosis Risk in Communities (ARIC) Study

ESSENTIALS: Galectin‐3, an inflammatory biomarker, is involved in murine thrombogenesis. Galectin‐3–binding protein is up‐regulated in microparticles from deep venous thrombosis patients compared to control patients. In this prospective epidemiological study, participants with plasma galectin‐3 conc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fashanu, Oluwaseun E., Heckbert, Susan R., Aguilar, David, Jensen, Paul N., Ballantyne, Christie M., Basu, Saonli, Hoogeveen, Ron C., deFilippi, Christopher, Cushman, Mary, Folsom, Aaron R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles: Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685543/ https://www.ncbi.nlm.nih.gov/pubmed/29152608 http://dx.doi.org/10.1002/rth2.12038

Ejemplares similares

Resting heart rate and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2019)

Hematocrit and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2020)

A prospective study of migraine history and venous thromboembolism in older adults
por: Folsom, Aaron R., et al.
Publicado: (2019)

Obesity, Galectin‐3, and Incident Heart Failure: The ARIC Study
por: Florido, Roberta, et al.
Publicado: (2022)

Levels and Change in Galectin‐3 and Association With Cardiovascular Events: The ARIC Study
por: Aguilar, David, et al.
Publicado: (2020)

Overall and abdominal obesity in relation to venous thromboembolism
por: Yuan, Shuai, et al.
Publicado: (2020)

Long‐Term Association of Venous Thromboembolism With Frailty, Physical Functioning, and Quality of Life: The Atherosclerosis Risk in Communities Study
por: Lutsey, Pamela L., et al.
Publicado: (2020)

Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort.
por: French, Simone A., et al.
Publicado: (2020)

Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population
por: Raskob, Gary E., et al.
Publicado: (2022)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study
por: Kats, Dmitry, et al.
Publicado: (2017)

Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study
por: Giustozzi, Michela, et al.
Publicado: (2021)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study
por: Vu, Khanh N., et al.
Publicado: (2016)

D‐dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta‐analysis
por: Bellesini, Marta, et al.
Publicado: (2021)

Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
por: Röshammar, Daniel, et al.
Publicado: (2021)

Genetic risk and incident venous thromboembolism in middle‐aged and older adults following COVID‐19 vaccination
por: Xie, Junqing, et al.
Publicado: (2022)

Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
por: Wiegers, Hanke M. G., et al.
Publicado: (2022)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022)

Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐Dimer analysis: A prospective study
por: Posch, Florian, et al.
Publicado: (2020)

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
por: Mulder, Frits I., et al.
Publicado: (2020)

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
por: Potere, Nicola, et al.
Publicado: (2022)

Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study
por: Raynor, L.A., et al.
Publicado: (2013)

Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis
por: Horner, Daniel, et al.
Publicado: (2019)

Resting heart rate and incident venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis
por: Awotoye, Josephine, et al.
Publicado: (2020)

Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement
por: Jameson, S. S., et al.
Publicado: (2014)

Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery—Systematic review and meta‐analysis
por: Presume, João, et al.
Publicado: (2022)

Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study
por: Jordan Bruno, Ximena, et al.
Publicado: (2022)

Lactate and Risk of Incident Diabetes in a Case-Cohort of the Atherosclerosis Risk in Communities (ARIC) Study
por: Juraschek, Stephen P., et al.
Publicado: (2013)

Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study
por: Hill, Jason B., et al.
Publicado: (2020)

Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism
por: Ward, Joey, et al.
Publicado: (2023)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study
por: Aronis, Konstantinos N., et al.
Publicado: (2017)

Fatigue after initiating rivaroxaban for venous thromboembolism
por: Karlsvik, Tina Margrethe, et al.
Publicado: (2020)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
por: Davila, Jennifer, et al.
Publicado: (2022)

Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study
por: Skajaa, Nils, et al.
Publicado: (2022)

Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative
por: Cushman, Mary, et al.
Publicado: (2018)

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vg4at1ohvid5dilbeaf9998l1e